Andres Gomez-Caminero, PhD, MPH
Head of Epidemiology, Saftey Science and Analytics at Bristol Myers Squibb
Public Health Interests
Current Public-Health Related Activities
I am currently involved in the development of risk management plans for drugs developed by BMS. The ultimate goal of these plans is to monitor and minimize the risk of adverse events once the drugs go into the general public.